KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Vertex Pharmaceuticals (VRTX) Debt Ratio (2016)

Vertex Pharmaceuticals (VRTX) has 6 years of Debt Ratio data on record, last reported at 0.1 in Q4 2016.

  • For Q4 2016, Debt Ratio rose 15.59% year-over-year to 0.1; the TTM value through Dec 2016 reached 0.1, up 15.59%, while the annual FY2016 figure was 0.1, 15.59% up from the prior year.
  • Debt Ratio reached 0.1 in Q4 2016 per VRTX's latest filing, down from 0.11 in the prior quarter.
  • Across five years, Debt Ratio topped out at 0.14 in Q1 2015 and bottomed at 0.09 in Q4 2015.
  • Average Debt Ratio over 3 years is 0.12, with a median of 0.12 recorded in 2016.
  • Peak YoY movement for Debt Ratio: decreased 29.04% in 2015, then increased 15.59% in 2016.
  • A 3-year view of Debt Ratio shows it stood at 0.13 in 2014, then decreased by 29.04% to 0.09 in 2015, then grew by 15.59% to 0.1 in 2016.
  • Per Business Quant database, its latest 3 readings for Debt Ratio were 0.1 in Q4 2016, 0.11 in Q3 2016, and 0.12 in Q2 2016.